Isolated congenital syngnathia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:141214Q67.4
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Isolated congenital syngnathia is an extremely rare craniofacial anomaly characterized by the fusion or adhesion of the upper jaw (maxilla) to the lower jaw (mandible). This condition is present at birth and results in a restricted or completely absent ability to open the mouth. The fusion may involve bony tissue (bony syngnathia), fibrous tissue, or soft tissue connections between the jaws. Syngnathia can occur as an isolated finding or in association with other congenital anomalies; in the isolated form (Orphanet code 141214), no other major malformations are present. The condition primarily affects the musculoskeletal and oral structures, and can significantly impair feeding, breathing, and airway management in the newborn period, making it a potentially life-threatening condition requiring urgent intervention. The key clinical feature is limited or absent mouth opening (trismus) noted immediately after birth. Affected neonates may present with feeding difficulties and respiratory distress due to the inability to open the oral cavity. Diagnosis is typically made on clinical examination and confirmed with imaging studies such as CT scanning to determine the nature and extent of the jaw fusion. Treatment is surgical and aims to release the fusion between the jaws to restore mouth opening and function. The surgical approach depends on the type of fusion (bony versus fibrous) and its extent. Early surgical intervention is often necessary to secure the airway and enable feeding. Post-operative management may include physiotherapy to maintain jaw mobility and prevent re-fusion. Long-term follow-up with a multidisciplinary team including oral and maxillofacial surgeons, pediatricians, and speech therapists may be required to optimize outcomes.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Isolated congenital syngnathia.

View clinical trials →

No actively recruiting trials found for Isolated congenital syngnathia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Isolated congenital syngnathia community →

No specialists are currently listed for Isolated congenital syngnathia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Isolated congenital syngnathia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Isolated congenital syngnathiaForum →

No community posts yet. Be the first to share your experience with Isolated congenital syngnathia.

Start the conversation →

Latest news about Isolated congenital syngnathia

No recent news articles for Isolated congenital syngnathia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Isolated congenital syngnathia

What is Isolated congenital syngnathia?

Isolated congenital syngnathia is an extremely rare craniofacial anomaly characterized by the fusion or adhesion of the upper jaw (maxilla) to the lower jaw (mandible). This condition is present at birth and results in a restricted or completely absent ability to open the mouth. The fusion may involve bony tissue (bony syngnathia), fibrous tissue, or soft tissue connections between the jaws. Syngnathia can occur as an isolated finding or in association with other congenital anomalies; in the isolated form (Orphanet code 141214), no other major malformations are present. The condition primarily

How is Isolated congenital syngnathia inherited?

Isolated congenital syngnathia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Isolated congenital syngnathia typically begin?

Typical onset of Isolated congenital syngnathia is neonatal. Age of onset can vary across affected individuals.